A Chinese scientist reviewing laboratory equipment

Research news

This section contains news items that were not issued as a press release.

Monday, 4 November 2013
A*STAR and AstraZeneca sign a research collaboration agreement to develop new antimicrobial drugs to combat Gram-negative bacterial infections Two units under Singapore’s Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Exploit Technologies Pte Ltd (ETPL) have signed a joint research collaboration agreement with global biopharmaceutical company AstraZeneca (AZ), to develop new drugs to treat Gram-negative bacterial infections. Such infections are believed to cause two thirds of all hospital acquired infection deaths.
Thursday, 17 October 2013
AstraZeneca announces ‘Open Innovation’ research collaboration with Taiwan’s research program for biopharmaceuticals AstraZeneca and Taiwan’s National Research Program for Biopharmaceuticals (NRPB) today announced a collaborative programme to support academic research proposals using ‘open innovation’ as a catalyst for drug discovery
Wednesday, 16 October 2013
Harvard's Wyss Institute and AstraZeneca Announce Collaboration on Organs-on-Chips for Drug Safety Testing Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and AstraZeneca announced a collaboration
Tuesday, 15 October 2013
TARIS® Biomedical Enters Research Collaboration with AstraZeneca TARIS Biomedical®, announced today that it has entered into a research collaboration with AstraZeneca to evaluate novel treatments for bladder cancer
Monday, 30 September 2013
AstraZeneca Oncology Update from European Cancer Congress in Amsterdam AstraZeneca and its global biologics research and development arm, MedImmune, presented oncology data at the European Cancer Congress (ECC) in Amsterdam this week (27 September – 1 October)
Tuesday, 10 September 2013
AstraZeneca and Hadasit announce drug discovery alliance AstraZeneca and Hadasit announce drug discovery alliance
Wednesday, 17 July 2013
AstraZeneca to Collaborate with Tufts University AstraZeneca and Tufts University’s School of Medicine and Sackler School of Graduate Biomedical Sciences are collaborating to establish a team of postdoctoral researchers that will work to advance understanding of diseases and disorders of the brain, including Alzheimer’s disease, Parkinson’s disease, neurodevelopmental and autism spectrum disorders. As part of a three-year agreement, the new team will conduct cutting-edge laboratory research into biological targets of interest in the field of neuroscience.
Wednesday, 26 June 2013
Roche and AstraZeneca launch medicinal chemistry data-sharing consortium to further accelerate drug discovery MedChemica to intermediate this unique collaboration
Tuesday, 25 June 2013
AstraZeneca and Karolinska Institutet sign agreement on integrated centre for cardiovascular and metabolic diseases AstraZeneca today announces the finalisation of a definitive agreement with Karolinska Institutet, Stockholm, Sweden regarding the establishment of a unique joint centre for research on cardiovascular and metabolic diseases.
Wednesday, 19 June 2013
Nobel Laureate Peter Agre speaks at the inaugural Nobel Prize Inspiration Initiative event in Russia On June 24-26 in Moscow and St.Petersburg, Professor Peter Agre, awarded the 2003 Nobel Prize in Chemistry, will participate in the Nobel Prize Inspiration Initiative, a global program that brings Nobel Laureates to universities and research centers to inspire and engage young scientists, the scientific community and the public.